AAAAAA
Results:
1-19
|
Results: 19
Lymphadenectomy for squamous cell carcinoma of the penis. Part 1: Diagnosis of lymph node metastasis
Authors:
Horenblas, S
Citation: S. Horenblas, Lymphadenectomy for squamous cell carcinoma of the penis. Part 1: Diagnosis of lymph node metastasis, BJU INT, 88(5), 2001, pp. 467-472
Authors:
Horenblas, S
Citation: S. Horenblas, Lymphadenectomy for squamous cell carcinoma of the penis. Part 2: The roleand technique of lymph node dissection, BJU INT, 88(5), 2001, pp. 473-483
Authors:
Fossa, SD
Slee, PHT
Brausi, M
Horenblas, S
Hall, RR
Hetherington, JW
Aaronson, N
de Prijck, L
Collette, L
Citation: Sd. Fossa et al., Flutamide versus prednisone in patients with prostate cancer symptomatically progressing after androgen-ablative therapy: A phase III study of the European Organization for Research and Treatment of Cancer Genitourinary Group, J CL ONCOL, 19(1), 2001, pp. 62-71
Authors:
Moonen, L
Ong, F
Gallee, M
Verheij, M
Horenblas, S
Hart, AAM
Bartelink, H
Citation: L. Moonen et al., Apoptosis, proliferation and p53, cyclin D1, and retinoblastoma gene expression in relation to radiation response in transitional cell carcinoma of the bladder, INT J RAD O, 49(5), 2001, pp. 1305-1310
Authors:
Olmos, RAV
Tanis, PJ
Hoefnagel, CA
Jansen, L
Nieweg, OE
Meinhardt, W
Horenblas, S
Citation: Rav. Olmos et al., Penile lymphoscintigraphy for sentinel node identification, EUR J NUCL, 28(5), 2001, pp. 581-585
Authors:
Roeleveld, TA
Horenblas, S
Meinhardt, W
van de Vijver, M
Kooi, M
Huinink, WWTB
Citation: Ta. Roeleveld et al., Surveillance can be the standard of care for stage I nonseminomatous testicular tumors and even high risk patients, J UROL, 166(6), 2001, pp. 2166-2170
Authors:
van Bezooijen, BPJ
Horenblas, S
Meinhardt, W
Newling, DWW
Citation: Bpj. Van Bezooijen et al., Laser therapy for carcinoma in situ of the penis, J UROL, 166(5), 2001, pp. 1670-1671
Authors:
Horenblas, S
Meinhardt, W
Ijzerman, W
Moonen, LFM
Citation: S. Horenblas et al., Sexuality preserving cystectomy and neobladder: Initial results, J UROL, 166(3), 2001, pp. 837-840
Authors:
Horenblas, S
Kroger, R
van Boven, E
Meinhardt, W
Newling, DWW
Citation: S. Horenblas et al., Use of balloon catheters for ureteral occlusion in urinary leakage, EUR UROL, 38(5), 2000, pp. 613-617
Authors:
Horenblas, S
von Krogh, G
Cubilla, AL
Dillner, J
Meijer, CJLM
Hedlund, PO
Citation: S. Horenblas et al., Squamous cell carcinoma of the penis: Premalignant lesions, SC J UROL N, 34, 2000, pp. 187-188
Authors:
Dillner, J
von Krogh, G
Horenblas, S
Meijer, CJLM
Citation: J. Dillner et al., Etiology of squamous cell carcinoma of the penis, SC J UROL N, 34, 2000, pp. 189-193
Authors:
Dillner, J
Meijer, CJLW
von Krogh, G
Horenblas, S
Citation: J. Dillner et al., Epidemiology of human papillomavirus infection, SC J UROL N, 34, 2000, pp. 194-200
Authors:
von Krogh, G
Horenblas, S
Citation: G. Von Krogh et S. Horenblas, The management and prevention of premalignant penile lesions, SC J UROL N, 34, 2000, pp. 220-229
Authors:
Horenblas, S
Jansen, L
Meinhardt, W
Hoefnagel, CA
de Jong, D
Nieweg, OE
Citation: S. Horenblas et al., Detection of occult metastasis in squamous cell carcinoma of the penis using a dynamic sentinel node procedure, J UROL, 163(1), 2000, pp. 100-104
Authors:
Horenblas, S
Meinhardt, W
Jansen, L
Citation: S. Horenblas et al., Lymphatic mapping and sentinel lympadenectomy in carcinoma of the penis, LYMPHATIC MAPPING AND PROBE APPLICATIONS IN ONCOLOGY, 2000, pp. 203-212
Authors:
Olmos, RAV
Hoefnagel, CA
Nieweg, OE
Jansen, L
Rutgers, EJT
Borger, J
Horenblas, S
Kroon, BBR
Citation: Rav. Olmos et al., Lymphoscintigraphy in oncology: a rediscovered challenge, EUR J NUCL, 26(4), 1999, pp. S2-S10
Authors:
van der Poel, HG
Roukema, JA
Horenblas, S
van Geel, AN
Debruyne, FMJ
Citation: Hg. Van Der Poel et al., Metastasectomy in renal cell carcinoma: A multicenter retrospective analysis, EUR UROL, 35(3), 1999, pp. 197-203
Authors:
Meinhardt, W
Horenblas, S
Citation: W. Meinhardt et S. Horenblas, Time to normalization of serum testosterone after 3-month luteinizing hormone-releasing hormone agonist administered in the neoadjuvant setting: Implications for dosing schedule and neoadjuvant study consideration, J UROL, 162(1), 1999, pp. 170-171
Authors:
Moonen, L
van der Voet, H
de Nijs, R
Hart, AAM
Horenblas, S
Bartelink, H
Citation: L. Moonen et al., Muscle-invasive bladder cancer treated with external beam radiotherapy: pretreatment prognostic factors and the predictive value of cystoscopic re-evaluation during treatment, RADIOTH ONC, 49(2), 1998, pp. 149-155
Risultati:
1-19
|